Marrone Bio Innov (MBII) Misses Q1 EPS by 14c

Marrone Bio Innov (NASDAQ: MBII) reported Q1 EPS of ($0.52), $0.14 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $4.63 million.

For earnings history and earnings-related data on Marrone Bio Innov (MBII) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Capstone Energy+, Inc. (CEPL) Reports Q2 Loss of $0.03
• Faraday Future stockholders approve $25M private placement proposal